| References |
1. Hisatome I, Tanaka Y, Sasaki N, Hiroe K, Ahmmed GU, Tsuboi M, Manabe I, Suga T, Yamamoto Y, Ohtahara A, Kinugawa T, Ogino K, Igawa O, Yoshida A, Saito M, Sato R, Shigemasa C. Influence of extracellular H+ and Ca2+ on Ro 22-9194-induced block of sodium current in cardiac myocytes. Gen Pharmacol. 1997 Oct;29(4):557-60. PubMed PMID: 9352302. 2. Karasaki S, Sato R, Katori R. The blocking mechanism of sodium currents by a new class I antiarrhythmic drug, Ro 22-9194, in isolated guinea-pig ventricular myocytes. Gen Pharmacol. 1997 Sep;29(3):379-86. PubMed PMID: 9378244. 3. Hiroe K, Hisatome I, Tanaka Y, Ahmmed GU, Sasaki N, Shimoyama M, Tsuboi M, Inoue Y, Manabe I, Yamamoto Y, Ohtahata A, Kinugawa T, Ogino K, Igawa O, Yoshida A, Shigemasa C, Sato R. Tonic block of the Na+ current in single atrial and ventricular guinea-pig myocytes, by a new antiarrhythmic drug, Ro 22-9194. Fundam Clin Pharmacol. 1997;11(5):402-7. PubMed PMID: 9342593. 4. Murakami M, Kinukawa M, Kanazawa T, Maruyama K, Miyagi M, Miyata H, Ujiie A. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. J Pharmacol Exp Ther. 1996 Nov;279(2):877-83. PubMed PMID: 8930195. |
